Clustering data with hclust algorithm for Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure (Study ST001140)

Sphingolipids (Analysis AN001871)
MetaboliteStructureF1F2F3F4
GlcCer(d18:2/24:0)ME272158NANA0.511.49
LacCer(d18:2/24:1)ME272168NANA1.130.87
GM3(d18:1/24:0)ME272142NANA1.020.98
LacCer(d18:1/23:0)ME272163NANA0.941.06
GM3(d18:2/20:0)ME2721461.100.90NANA
LacCer(d18:2/22:0)ME2721671.190.81NANA
Cer(d18:2/18:0)ME2721340.561.44NANA
GlcCer(d18:2/16:0)ME2721570.731.27NANA
GM3(d18:1/18:0)ME2721401.320.881.190.54
GM3(d18:2/18:0)ME2721451.290.801.480.39
Cer(d18:2/24:1)ME2721380.651.181.181.05
GM3(d18:2/24:1)ME2721470.820.931.550.79
GM3(d18:2/16:0)ME2721440.950.751.341.05
SM(42:3)ME2721850.920.871.350.94
LacCer(d18:2/16:0)ME2721660.730.890.971.54
Cer(d18:1/24:1)ME2721300.821.060.761.40
SM(36:1)ME2721740.950.910.661.53
Cer(d18:1/18:0)ME2721250.690.990.521.92
GlcCer(d18:1/18:0)ME2721500.611.300.461.66
GlcCer(d18:1/16:0)ME2721480.701.370.751.15
GlcCer(d18:1/24:1)ME2721550.671.400.761.14
GlcCer(d18:1/16:1)ME2721490.731.290.701.28
GlcCer(d18:1/20:0)ME2721510.721.360.631.26
GlcCer(d18:1/22:0)ME2721520.781.610.461.02
GlcCer(d18:1/23:0)ME2721530.711.530.581.11
GlcCer(d18:1/24:0)ME2721540.791.520.591.01
GlcCer(d18:1/25:0)ME2721560.821.480.620.97
SM(32:2)ME2721701.160.801.270.79
GM3(d18:1/16:0)ME2721391.170.911.030.87
SM(32:1)ME2721691.170.901.050.85
GM3(d18:1/24:1)ME2721431.091.011.150.72
SM(41:2)ME2721821.120.961.130.75
SM(36:2)ME2721750.960.811.091.22
LacCer(d18:1/18:0)ME2721600.960.960.891.21
SM(34:2)ME2721731.030.881.011.11
SM(42:2)ME2721841.010.990.991.02
Cer(d18:2/16:0)ME2721330.961.071.080.89
SM(43:2)ME2721871.130.980.940.91
SM(34:1)ME2721721.170.970.840.97
LacCer(d18:1/20:0)ME2721611.101.030.860.97
SM(38:2)ME2721771.081.020.871.00
SM(39:1)ME2721781.461.110.660.58
GM3(d18:1/22:0)ME2721411.131.220.800.73
SM(40:2)ME2721801.241.050.930.70
SM(43:1)ME2721861.191.110.760.84
SM(41:1)ME2721811.241.070.680.90
SM(42:1)ME2721831.241.110.690.84
Cer(d18:2/22:0)ME2721351.361.080.660.76
Cer(d16:1/24:0)ME2721231.321.150.580.79
SM(40:1)ME2721791.361.090.570.83
Cer(d18:1/22:0)ME2721271.381.030.500.95
Cer(d18:1/25:0)ME2721311.300.920.641.06
Cer(d18:1/20:0)ME2721261.170.960.471.35
Cer(d18:1/25:1)ME2721320.991.090.601.30
SM(38:1)ME2721761.161.000.641.15
Cer(d18:1/23:0)ME2721281.181.090.571.07
Cer(d18:1/24:0)ME2721291.141.080.551.15
LacCer(d18:1/22:0)ME2721621.101.130.690.99
SM(34:0)ME2721711.041.020.721.20
LacCer(d18:1/24:0)ME2721641.041.100.681.12
SM(44:1)ME2721881.081.060.711.10
LacCer(d18:1/16:0)ME2721590.931.120.891.06
LacCer(d18:1/24:1)ME2721650.921.110.781.19
Cer(d18:2/23:0)ME2721360.951.280.800.88
Cer(d18:1/16:0)ME2721240.941.270.691.04
Cer(d18:2/24:0)ME2721370.941.230.671.10

Factors:

F1TreatmentGroup:Prednisolone | TreatmentDuration:0d | SamplingTimePoint:before
F2TreatmentGroup:Prednisolone | TreatmentDuration:4d | SamplingTimePoint:after
F3TreatmentGroup:Tetracosactide | TreatmentDuration:00w | SamplingTimePoint:before
F4TreatmentGroup:Tetracosactide | TreatmentDuration:25w | SamplingTimePoint:after
Data matrix
  logo